clinical trials
Harvest One Executing on Brands and Distribution Strategy
The nature of the compelling stories in the cannabis industry has changed over the last few years. Remember when a late-stage ACMPR applicant was all the rage? Then it was production expansion and funded capacity. Now, all of that potential is turning to the reality of any market – who can sell product and generate […]
Harvest One Completes First Shipment to Shoppers Drug Mart
SatiSilver™ & SatiGreen™ Now Available for Purchase VANCOUVER, March 21, 2019 /PRNewswire/ – Harvest One Cannabis Inc. (“Harvest One” or the “Company”) (TSXV: HVT; OTCQX: HRVOF), through it’s wholly-owned subsidiary United Greeneries Ltd. (“United Greeneries”), today announced that it has completed its first shipment to Shoppers Drug Mart of Satipharm branded cannabis. Satipharm branded cannabis is now available for […]
Interview with Gabriella’s Kitchen CEO Margot Micallef
CFN Media recently sat down with Gabriella’s Kitchen (CSE: GABY) (OTCBB:GABLF) CEO Margot Micallef to discuss the global implications of Gaby’s innovative products. New beginnings Gabriella’s Kitchen is a cannabis wellness company founded in health and nutrition. Spurred by a dire cancer prognosis, sisters Gabriella and Margot sought a healthier lifestyle that might prolong Gabriella’s life. […]
CFN Media Exclusive Interview with Creso Pharma COO John Griese
The global cannabis industry is projected to hit $150 billion by 2025, according to Grand View Research, driven by the legalization of recreational and medical cannabis across a growing number of jurisdictions. Creso Pharma is positioned well to generate revenues from around the world. Creso Pharma Inc.(ASX: CPH) recently received a Canadian license to cultivate for […]
Creso Pharma Secures Canadian License to Cultivate in Nova Scotia
Creso Pharma Inc.(ASX: CPH) is a commercial-stage company that operates in multiple parts of the burgeoning cannabis industry. With an existing line of health and wellness products, the company is actively generating revenue across European markets. The company’s recently granted license to cultivate in Nova Scotia provides additional exposure to Canada’s recreational and medical markets and […]
FSD Pharma’s Investments in Cutting-Edge Tech Could Pay Big Dividends
Many cannabis companies have predictable business models—they grow and sell cannabis flower or perhaps extract them into edibles or vape pens. While most companies are focused on maximizing their production footprint, some companies have placed an additional focus on research and development. These investments could pay big dividends in the future if they prove to […]
Aleafia Becomes First Cannabis Stock to Top TSX Venture 50 Performance Rankings
The TSX Venture exchange has become a popular place for cannabis companies to list their shares, particularly after Canada legalized recreational cannabis last year, but 2019 was the first year that a cannabis company topped its annual performance rankings. Aleafia Health Inc. (TSX-V: ALEF) (OTCQX: ALEAF) (FRA: ARAH), a vertically-integrated licensed producer with a clinic […]
Helix TCS Subsidiary, BioTrackTHC, Receives NCIA Excellence in Innovation Award
DENVER, Feb. 14, 2019 /PRNewswire/ — Helix TCS (OTCQB: HLIX) (the “Company”) subsidiary, BioTrackTHC, was presented with an award for Excellence in Innovation in the category of Business Strategy and Innovation by the National Cannabis Industry Association (“NCIA”), the largest and longest running non-profit association in the legal cannabis industry. The award, which was presented yesterday […]
Yield Growth Expanding Product Lines & Distribution Footprint
There’s no doubt that the cannabis industry is poised for rapid growth over the coming quarters, but investors have many options in the space. While licensed producers and retailers tend to capture the headlines, investors may want to take a closer look at companies developing innovative products lines in high-growth segments, such as the beverage, […]
Chemesis International Inc. Acquires Intellectual Property for High-Quality Cannabis Extraction
Chemesis acquires the IP and physical extraction equipment for a methodology that utilizes a low-temperature process to produce a high concentration cannabis oil that preserves all constituents and phytocannabinoids VANCOUVER, British Columbia, Feb. 07, 2019 (GLOBE NEWSWIRE) — Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces it has acquired intellectual property (“IP”) […]
The Green Organic Dutchman Provides Construction Update and Increases Capacity
The Green Organic Dutchman Provides Construction Update and Increases Capacity TORONTO, Feb. 1, 2019 /PRNewswire/ – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX: TGOD) (US: TGODF) is providing a detailed construction update on its domestic Valleyfield and Hamilton operations where significant progress has been made towards the completion of both facilities. TGOD […]
Transcanna Provides Investors with Exposure to Ancillary Cannabis Businesses
The global cannabis industry is projected to reach more than $150 billion by 2025, according to Grand View Research, driven by legalization across a growing number of countries. While most investors are focused on cannabis cultivators and retailers, these companies still face legal and logistical challenges in many jurisdictions. Ancillary service providers may be better […]
Pascal Biosciences Commences Cannabinoid Testing of Human Volunteers and Patients
VANCOUVER, British Columbia, and SEATTLE, Jan. 24, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the testing of cannabinoids in human subjects for its immune stimulatory program in cancer. Furthermore, the Company has filed an international patent application to protect this work for […]
Creso Pharma Gears Up for Adult-Use Market with New Supply Agreement
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of adult-use cannabis in October of last year. While many licensed producers have been scaling up their production, the market continues to experience a shortfall in supply that has created an opportunity for investors […]
Transcanna Holdings Inc. (CSE:TCAN) (“TransCanna” or the “Company”) is pleased to announce that TCM Distribution, Inc. (“TCMD”), the non-profit entity managed by the Company has received from the state of California its temporary distributor license. On December 31st TCMD submitted its permanent distribution license application to the state of California. On November 23rd, 2018 TCM Distribution, […]
The Alkaline Water Company Partners with Water Source One
Agreement Expands Production and Distribution Capabilities SCOTTSDALE, Ariz., Jan. 18, 2019 (GLOBE NEWSWIRE) — The Alkaline Water Company Inc. (NASDAQ and TSXV: WTER)(the “Company”), a leading producer of premium bottled alkaline drinking water sold under the brand name Alkaline88®, today announced it has entered into a Management and Services Agreement with Austin, Texas-based Water Source One (“WSO”) […]
Aleafia Health Completes Strategic Investment in Australia’s CannaPacific Pty Limited
Global Expansion Underway with 10% Equity Investment in Licensed Cannabis Cultivator CannaPacific among Australia’s only Federally Licensed Cultivators with projected 108,000 sq. ft. Greenhouse More TORONTO, Jan. 18, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) (“Aleafia Health”) or the (“Company”) is announcing its global expansion with the closing of […]
FSD Pharma Completes Harvest And Passes Analytical Testing Of Second Lot
Company in position for pre-sales license inspection, last step to issuance of a Sales License – CSE: HUGE OTC: FSDDF FRA: 0K9 TORONTO, January 8, 2019 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) is pleased to announce that its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”), a licensed […]
Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
– 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic – Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced a year-end review of accomplishments during 2018 and insight into plans […]
Canntab Partners with Leading Surgeon to Conduct Pain Management Trial
The opioid industry is expected to generate nearly $20 billion in annual revenue by 2020, but the addictive nature of the drug has doctors and patients increasingly concerned. With the legalization of cannabis across Canada and many U.S. states, there’s an opportunity to replace dangerous opioids with efficacious cannabinoids to treat chronic and acute pain. […]
From The Ground Up: City View Green Is Building A Winning Cannabis Strategy Piece By Piece
The Canadian cannabis industry is ripe with targets for mergers and acquisitions. For Rob Fia, CEO of Icon Exploration (TSX-V- IEX), which is completing a reverse takeover of private company City View Green (CVG), the idea of building a state-of-the art cannabis company from the ground up offered a better value proposition. In just over […]
Icon Exploration Inc. Discusses its Cannabis Strategy in Exclusive NetworkNewsWire Audio Interview
NEW YORK, Dec. 12, 2018 (GLOBE NEWSWIRE) — via NetworkNewsAudio – NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the online availability of its interview with Icon Exploration Inc. (TSX.V: IEX.H), a client of NNW currently focused on assessing potential acquisition targets […]
Pascal Biosciences Announces Year-End Investor Update Webcast
Advancement of Cannabinoid Cancer Programs and Corporate Review to be Presented Scheduled for Dec. 17, 2018 at 1:30 p.m. Pacific VANCOUVER, British Columbia and SEATTLE, Dec. 10, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, announced today it will host a year-end investor update webcast […]
NanoSphere Forms Strategic Partnership to Launch Evolve Products in Mexico
VANCOUVER, British Columbia Agreement will bring the patented NanoSphere Delivery System™ to an emerging $5 billion cannabis market NanoSphere Health Sciences Inc. (CSE:NSHS) (OTC:NSHSF) (“NanoSphere” or “the Company”), the biotechnology leader behind the patented NanoSphere Delivery System™, is pleased to announce the Company has signed a Letter of Intent forming a partnership with Abba Import […]
NexTech Looks to Bring Augmented Reality to Ecommerce
Ecommerce spending is projected to rise from $2.3 trillion in 2017 to $4.5 trillion by 2021, according to Statista, as consumers transition from brick-and-mortar to online shopping. While desktops still represent about 60 percent of the market, mobile ecommerce users have grown to capture about 40 percent of the market. New technologies, like augmented reality, […]
Creso Pharma: A Truly Global Cannabis Company
The North American cannabis industry is littered with companies touting global ambitions. There are regular announcements regarding letters of intent to distribute in emerging markets like Europe and Latin America, long on potential and short on concrete details. Many of these announcements are speculative at best, requiring a mix of regulatory approvals, licensing, product development, […]
VANCOUVER, BRITISH COLUMBIA, and SEATTLE, WASHINGTON, November 28, 2018 – Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the strengthening of its leadership team with the appointments of seasoned executives in therapeutic and business development. These include Kevin M. Egan, MBA, Vice President Business Development, Thomas Deckwerth, […]
FSD Pharma’s New CEO is a Top GW Pharma Executive
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, but the market pales in comparison to the global pharmaceutical industry—which could reach more than $1 trillion by 2020. Cannabis investors shouldn’t ignore the medical side of the business, which emerging research suggests could revolutionize several medical fields—especially in […]
Halo Labs: Improving Investor Reach, Transparency, and Liquidity
The cannabis industry has rapidly evolved over the past year. In addition to the federal legalization of adult-use cannabis in Canada, the United States’ midterm elections could foretell a shift in federal policy over the coming months. Investors have many different options when looking for exposure to the industry, but it’s important to look at […]
Lexaria Targets Cannabinoids, Tobacco, Hemp, and Pharma Markets with New Subsidiaries
The cannabis industry is projected to generation hundreds of billions of dollars of revenue over the coming years, driven by the legalization of medical and recreational cannabis across North America. While many investors are focused on cultivation or dispensary operations, drug delivery technologies may represent an even bigger opportunity. These companies have an opportunity to […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
Pivot Pharmaceuticals Inc. is an emerging biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals.
JWC is a Licensed Producer under the ACMPR with the goal of helping patients by providing clean, consistent medical cannabis products.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
